Unraveling a Biomedical Mystery: New gift boosts MCDB professor’s work toward therapy for polycystic kidney disease

Nov 12, 2014

With no cure, no approved treatment and no known means of slowing its progression, polycystic kidney disease is a biomedical cold case that affects more than 600,000 people in the U.S. alone — and some 12 million worldwide. Hoping to crack that case with science, MCDB professor Thomas Weimbs is working to develop a new therapeutic approach by targeting the mechanism that causes the cysts to grow. A new gift to his lab by the Lillian Goldman Charitable Trust of New York is providing a big boost to that effort.

Related Links